Details for Patent: 9,095,577
✉ Email this page to a colleague
Which drugs does patent 9,095,577 protect, and when does it expire?
Patent 9,095,577 protects ZUPLENZ and is included in one NDA.
Summary for Patent: 9,095,577
| Title: | Stabilized amine-containing actives in oral film compositions |
| Abstract: | The present invention relates to compositions relating to films containing active pharmaceutical agents. In particular, the present invention relates to methods and systems useful for stabilizing amine-containing actives for dispersion in a film product. |
| Inventor(s): | Garry L. Myers, Madhu Sudan Hariharan, Kevin Davidson, Pradeep Sanghvi |
| Assignee: | Aquestive Therapeutics Inc |
| Application Number: | US14/635,851 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Compound; |
Drugs Protected by US Patent 9,095,577
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aquestive | ZUPLENZ | ondansetron | FILM;ORAL | 022524-001 | Jul 2, 2010 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| Aquestive | ZUPLENZ | ondansetron | FILM;ORAL | 022524-002 | Jul 2, 2010 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
